Rock Springs Capital Management LP Global Blood Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $15.2 Million - $21.5 Million	-288,279 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $403,435 - $677,387	8,279 Added 2.96%	288,279 $18.2 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $625,800 - $1.31 Million	15,000 Added 5.66%	280,000 $14.3 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $1.05 Million - $1.27 Million	20,000 Added 8.16%	265,000 $13.9 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $3 Million - $4.43 Million	95,000 Added 63.33%	245,000 $10.1 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $3.77 Million - $4.66 Million	150,000	150,000 $4.66 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.